NASDAQ : ADXN
Addex Therapeutics Ltd — Financial statements
Healthcare · Biotechnology · Switzerland
Last price 3.09 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.35M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Addex Therapeutics Ltd (ADXN) reported revenue of 83.07K CHF (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 29.97K | 29.97K | 404.10K | 1.61M | 1.42M | 2.92M |
| Other Revenue | 53.10K | 142.89K | 5.94K | 4.24K | 22.52K | 237.00K |
| Revenue | 83.07K | 172.86K | 410.04K | 1.62M | 1.44M | 3.15M |
| Cost of Revenue | 355.25K | 671.65K | 854.30K | 1.19M | 8.23M | 12.82M |
| Gross Profit | -272.18K | -498.79K | -444.26K | 430.50K | -6.78M | -9.67M |
| Selling, General & Admin | 2.33M | 2.32M | 2.31M | 2.67M | 3.76M | 5.84M |
| Operating Expenses | 2.33M | 2.32M | 2.31M | 2.67M | 3.76M | 5.84M |
| Operating Income | -2.60M | -2.81M | -2.76M | -2.24M | -10.54M | -15.51M |
| Interest Expense | -3.18K | -2.42K | -3.55K | -3.87K | -27.95K | -63.01K |
| Interest & Investment Income | 9.16K | 63.96K | 29.25K | 5.32K | ||
| Earnings From Equity Investments | -4.26M | -4.01M | -2.18M | |||
| Currency Exchange Gain (Loss) | 500.00 | -13.13K | 17.43K | -317.29K | -264.36K | 211.69K |
| EBT Excluding Unusual Items | -6.87M | -6.84M | -4.91M | -2.50M | -10.80M | -15.35M |
| Pretax Income | -6.87M | -6.84M | -4.91M | -2.50M | -10.80M | -15.35M |
| Earnings From Continuing Operations | -6.87M | -6.84M | -4.91M | -2.50M | -10.80M | -15.35M |
| Earnings From Discontinued Operations | -3.40K | 114.34K | 11.97M | -8.06M | -10.00M | |
| Net Income | -6.87M | -6.73M | 7.06M | -10.56M | -20.80M | -15.35M |
| Net Income to Common | -6.87M | -6.73M | 7.06M | -10.56M | -20.80M | -15.35M |
| Shares Outstanding (Basic) | 118.14M | 107.37M | 98.11M | 74.31M | 45.18M | 34.12M |
| Shares Outstanding (Diluted) | 118.14M | 107.37M | 98.11M | 74.31M | 45.18M | 34.12M |
| EPS (Basic) | -0.06 | -0.06 | 0.07 | -0.14 | -0.46 | -0.45 |
| EPS (Diluted) | -0.06 | -0.06 | 0.07 | -0.14 | -0.46 | -0.45 |
| Free Cash Flow | -2.39M | -2.17M | -5.37M | -8.00M | -16.44M | -14.74M |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.06 | -0.11 | -0.36 | -0.43 |
| Gross Margin | -288.55% | -108.35% | 26.62% | |||
| Operating Margin | -3,130.67% | -1,628.25% | -671.94% | -138.70% | -729.50% | -491.74% |
| Profit Margin | -8,271.00% | -3,892.31% | 1,720.75% | -652.75% | -1,439.78% | -486.85% |
| Free Cash Flow Margin | -2,873.12% | -1,256.00% | -1,310.80% | -494.64% | -1,137.59% | -467.34% |
| EBITDA | -2.60M | -2.81M | -2.56M | -2.23M | -10.53M | -15.16M |
| EBITDA Margin | -137.97% | |||||
| D&A For EBITDA | -3.60K | 424.00 | 192.70K | 11.75K | 8.81K | 347.61K |
| EBIT | -2.60M | -2.81M | -2.76M | -2.24M | -10.54M | -15.51M |
| EBIT Margin | -138.70% |
Balance sheet
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 767.33K | 1.64M | 3.34M | 3.87M | 6.96M | 20.48M |
| Cash & Short-Term Investments | 767.33K | 1.64M | 3.34M | 3.87M | 6.96M | 20.48M |
| Receivables | 29.75K | 20.09K | 15.51K | 151.27K | 598.32K | 324.42K |
| Prepaid Expenses | 237.45K | 16.30K | 169.65K | 217.01K | 270.39K | 1.12M |
| Other Current Assets | 3.98K | 5.13K | 14.46K | 848.00 | 3.17K | 17.14K |
| Total Current Assets | 1.04M | 1.68M | 3.54M | 4.23M | 7.83M | 21.94M |
| Property, Plant & Equipment | 76.22K | 34.24K | 42.71K | 352.94K | 398.73K | 542.10K |
| Long-Term Investments | 1.80M | 4.13M | 7.09M | |||
| Other Long-Term Assets | 563.61K | 516.15K | 7.09K | 54.34K | 54.35K | 57.91K |
| Total Assets | 3.48M | 6.36M | 10.68M | 4.64M | 8.28M | 22.54M |
| Accounts Payable | 776.03K | 602.90K | 253.29K | 984.38K | 1.28M | 1.79M |
| Accrued Expenses | 486.91K | 588.38K | 541.50K | 1.40M | 1.72M | 2.06M |
| Current Portion of Leases | 54.47K | 7.68K | 7.31K | 273.96K | 286.11K | 287.70K |
| Current Unearned Revenue | 234.98K | |||||
| Total Current Liabilities | 1.36M | 1.20M | 802.09K | 2.89M | 3.28M | 4.13M |
| Long-Term Leases | 23.02K | 27.01K | 34.69K | 70.38K | 87.03K | 194.32K |
| Long-Term Unearned Revenue | 89.23K | |||||
| Pension & Post-Retirement Benefits | 184.85K | 371.61K | 164.25K | 443.52K | 1.28M | |
| Total Liabilities | 1.57M | 1.60M | 1.00M | 3.50M | 3.37M | 5.61M |
| Common Stock | 2.19M | 2.19M | 1.84M | 1.84M | 1.15M | 49.27M |
| Additional Paid-In Capital | 267.62M | 267.31M | 266.38M | 266.19M | 269.51M | 283.98M |
| Retained Earnings | -363.55M | -360.09M | -353.36M | -360.42M | -349.86M | -329.06M |
| Treasury Stock | -921.77K | -1.01M | -869.71K | -909.57K | -6.28M | -11.70M |
| Comprehensive Income & Other | 96.57M | 96.38M | 95.68M | 94.44M | 90.39M | 24.44M |
| Shareholders' Equity | 1.91M | 4.77M | 9.68M | 1.15M | 4.91M | 16.93M |
| Total Liabilities & Equity | 3.48M | 6.36M | 10.68M | 4.64M | 8.28M | 22.54M |
| Total Debt | 77.50K | 34.69K | 41.99K | 344.34K | 373.13K | 482.01K |
| Net Cash (Debt) | 689.83K | 1.60M | 3.30M | 3.52M | 6.58M | 20.00M |
| Net Cash Per Share | 0.01 | 0.01 | 0.03 | 0.05 | 0.15 | 0.59 |
| Filing Date Shares Outstanding | 127.41M | 117.93M | 98.34M | 128.26M | 80.88M | 37.90M |
| Total Common Shares Outstanding | 127.41M | 117.93M | 98.34M | 125.20M | 77.13M | 37.90M |
| Working Capital | -326.37K | 481.16K | 2.74M | 1.34M | 4.55M | 17.81M |
| Book Value Per Share | 0.01 | 0.04 | 0.10 | 0.01 | 0.06 | 0.45 |
| Tangible Book Value | 1.91M | 4.77M | 9.68M | 1.15M | 4.91M | 16.93M |
| Tangible Book Value Per Share | 0.01 | 0.04 | 0.10 | 0.01 | 0.06 | 0.45 |
| Machinery | 84.78K | 1.13K | 84.78K | 1.73M | 1.72M | 1.72M |
Cash flow statement
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -6.87M | -6.73M | 7.06M | -10.56M | -20.80M | -15.35M |
| Depreciation & Amortization | 39.28K | 8.47K | 192.70K | 11.75K | 8.81K | 347.61K |
| Loss (Gain) on Equity Investments | 4.26M | 4.01M | 2.18M | |||
| Stock-Based Compensation | 40.75K | 70.82K | 175.28K | 280.20K | 677.71K | 1.34M |
| Other Operating Activities | -19.27K | 30.39K | -175.95K | 293.45K | 197.56K | -282.64K |
| Change in Accounts Receivable | 23.03K | -4.57K | 134.01K | 447.05K | -273.89K | -256.05K |
| Change in Accounts Payable | 68.72K | 391.23K | -1.15M | -613.21K | -427.39K | 883.84K |
| Change in Unearned Revenue | -38.40K | 324.21K | -820.15K | |||
| Change in Other Net Operating Assets | 64.10K | 162.69K | -177.90K | 55.70K | 858.96K | -569.21K |
| Operating Cash Flow | -2.39M | -2.17M | -5.37M | -7.99M | -16.44M | -14.71M |
| Capital Expenditures | -1.27K | -6.84K | -581.00 | -31.55K | ||
| Investment in Securities | -285.96K | 3.55K | 1.24K | |||
| Other Investing Activities | 56.67K | -394.73K | 4.65M | |||
| Investing Cash Flow | 56.67K | -680.69K | 4.65M | -6.84K | 2.97K | -30.31K |
| Long-Term Debt Repaid | -7.31K | -73.69K | -281.79K | -288.08K | -309.62K | |
| Lease Payments | -37.91K | -7.31K | -73.69K | -281.79K | -288.08K | -309.62K |
| Net Debt Issued (Repaid) | -37.91K | -7.31K | -73.69K | -281.79K | -288.08K | -309.62K |
| Issuance of Common Stock | 862.78K | 1.23M | 240.90K | 2.35M | 1.68M | 13.96M |
| Repurchase of Common Stock | -28.11K | -35.14K | -25.78K | -48.05K | -307.50K | -390.19K |
| Other Financing Activities | -4.95K | -2.42K | -36.51K | 3.24M | 2.02M | 3.14M |
| Financing Cash Flow | 791.81K | 1.18M | 104.92K | 5.26M | 3.10M | 16.40M |
| Foreign Exchange Rate Adjustments | 4.53K | -35.19K | 99.68K | -356.95K | -196.22K | 122.47K |
| Net Cash Flow | -1.53M | -1.70M | -523.74K | -3.09M | -13.53M | 1.79M |
| Free Cash Flow | -2.39M | -2.17M | -5.37M | -8.00M | -16.44M | -14.74M |
| Free Cash Flow Margin | -2,873.12% | -1,256.00% | -1,310.80% | -494.64% | -1,137.59% | -467.34% |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.06 | -0.11 | -0.36 | -0.43 |
| Levered Free Cash Flow | -1.44M | -1.27M | -3.36M | -993.09K | -6.19M | -8.20M |
| Unlevered Free Cash Flow | -1.43M | -1.27M | -3.36M | -990.67K | -6.17M | -8.16M |
| Free Cash Flow After Leases | -2.42M | -2.18M | -5.45M | -8.28M | -16.73M | -15.05M |
| Cash Interest Paid | 3.18K | 2.42K | 9.22K | 21.61K | 48.90K | 63.01K |
| Change in Working Capital | 155.86K | 549.35K | -1.23M | 213.76K | 157.68K | -761.57K |
Ratios
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.05M | 8.14M | 6.21M | 7.34M | 11.23M | 43.24M |
| Enterprise Value | 5.21M | 5.43M | 2.56M | 2.08M | 442.95K | 26.83M |
| Last Close Price | 3.09 | 7.72 | 7.00 | 6.05 | 12.60 | 125.80 |
| PE Ratio | 0.80 | |||||
| PS Ratio | 58.81 | 37.36 | 13.72 | 3.82 | 7.19 | 12.50 |
| PB Ratio | 2.56 | 1.35 | 0.58 | 5.40 | 2.11 | 2.33 |
| P/TBV Ratio | 2.56 | 1.35 | 0.58 | 5.40 | 2.11 | 2.33 |
| EV/Sales Ratio | 50.67 | 24.92 | 5.66 | 1.08 | 0.28 | 7.75 |
| Debt / Equity Ratio | 0.04 | 0.01 | 0.00 | 0.30 | 0.08 | 0.03 |
| Net Debt / Equity Ratio | -0.36 | -0.34 | -0.34 | -3.07 | -1.34 | -1.18 |
| Net Debt / EBITDA Ratio | 0.27 | 0.57 | 1.29 | 1.58 | 0.62 | 1.32 |
| Net Debt / FCF Ratio | 0.29 | 0.74 | 0.61 | 0.44 | 0.40 | 1.36 |
| Asset Turnover | 0.01 | 0.02 | 0.05 | 0.25 | 0.09 | 0.15 |
| Quick Ratio | 0.58 | 1.38 | 4.19 | 1.39 | 2.30 | 5.03 |
| Current Ratio | 0.76 | 1.40 | 4.42 | 1.46 | 2.38 | 5.31 |
| Return on Equity (ROE) | -150.58% | -94.75% | -90.72% | -82.53% | -98.92% | -97.35% |
| Return on Assets (ROA) | -27.12% | -20.64% | -22.48% | -21.69% | -42.75% | -45.37% |
| Return on Capital Employed (ROCE) | -122.90% | -54.50% | -27.90% | -128.30% | -210.80% | -84.20% |
| Earnings Yield | -274.14% | -104.18% | 125.46% | -170.78% | -200.32% | -38.95% |
| FCF Yield | -47.91% | -33.62% | -95.57% | -129.41% | -158.28% | -37.39% |
| Buyback Yield / Dilution | -19.49% | -9.44% | -32.04% | -64.45% | -32.43% | -27.88% |